Japan’s approval of the world’s first self-amplifying mRNA (saRNA) vaccine for COVID-19 has ignited a firestorm of controversy. Critics have dubbed this new technology the “third atomic bomb,” drawing a provocative parallel to the country’s traumatic past. The vaccine, called ARCT-154 or Kostaive, received approval in November 2023 and was introduced on October 1, 2024. […]
Related Posts
Nile Dam Talks Resume Among Egypt, Sudan, and Ethiopia
Egypt, Sudan, and Ethiopia are back at the discussion table about the disputed dam on the Blue Nile. The talks kicked off this weekend in Ethiopia’s capital, Addis Ababa. The Ethiopian Foreign Ministry announced the news, emphasizing their commitment to peaceful solutions. Interestingly, this comes two weeks after Ethiopia wrapped up the last filling phase […]
China’s Markets Face Major Outflows from International Investors
In January, China’s stock market experienced a significant shift as foreign investors withdrew a net amount of 14.5 billion yuan ($2 billion) from mainland shares. According to Nikkei Asia, this marked the largest outflow since the 2014 inception of the Hong Kong-mainland Stock Connect. Starting in August 2023, this trend has led to six months […]
LatAm’s lithium industry races ahead to attract investment and maintain global leadership position
Latin America is at the forefront of supplying a crucial resource for electric vehicle batteries: lithium. With at least 17 projects underway or about to commence in Argentina, Chile, Brazil, and Bolivia, the region seeks to secure its position in the industry by fostering a favorable business environment and avoiding potential investment losses to other […]